首页> 外文期刊>Thoracic cancer. >The South Region Cancer Registry: an evaluation of its exhaustiveness in a cohort of lung cancer patients
【24h】

The South Region Cancer Registry: an evaluation of its exhaustiveness in a cohort of lung cancer patients

机译:南部地区癌症登记处:评估其肺癌患者队列的详尽

获取原文
获取外文期刊封面目录资料

摘要

The regional cancer registry for Southern Portugal (ROR-Sul) is a population-based registry set up in 1988 to observe and monitor disease incidence, prevalence and survival. Recently, the need to monitor real-life use of early approved and high-priced medicines led to therapeutic effectiveness becoming an emerging area of interest. We aimed to evaluate the exhaustiveness of the ROR-Sul database, covering around 4.8 million inhabitants. We have used a retrospective cohort study comprising 3457 lung cancer cases diagnosed during 2014 and 2015 and extracted from ROR-Sul database. Descriptive analysis of missing data was undertaken using IBM SPSS software, v.24. Exhaustiveness of data registry was classified into high (missing values 15%). High exhaustiveness was found for patients demographic information, date of diagnosis, date of first medical appointment, topography, morphology, cancer differentiation, stage of disease and surgery procedure. Medium exhaustiveness was found for biomarkers (ALK, KRAS, and EGFR) results, and immunotherapy regimens. Low exhaustiveness was found for performance status, chemotherapy regimen, and chemotherapy treatment response. The findings highlight the need to transform treatment variables into compulsory, so that the cancer registry may be used to support effectiveness studies. Education, training and behaviour changes must also be considered to foster the process. ? 2018 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:葡萄牙南部(ROR-SUL)的区域癌症登记处是一家以1988年成立的基于人口的注册处,观察和监测疾病发病率,患病率和生存。最近,需要监测早期批准和高价药物的现实生活使用导致治疗效果成为新兴的兴趣领域。我们旨在评估ROR-SUL数据库的详尽,涵盖约480万居民。我们使用了一项回顾性队列研究,该研究包括2014年和2015年诊断的3457例肺癌病例,并从ROR-SUL数据库中提取。使用IBM SPSS软件,V.24进行了对缺失数据的描述性分析。数据注册表的详尽归入高(缺少值15%)。为患者人口统计信息,诊断日期,首次医疗约会日期,地形,形态,癌症分化,疾病和手术阶段的诊断日期。发现了生物标志物(ALK,KRA和EGFR)结果和免疫疗法方案的中等详细程度。发现性能状况,化疗方案和化疗治疗反应的低详细程度。调查结果突出了将处理变量转化为强制性的需要,以便癌症登记处可用于支持有效性研究。也必须考虑教育,培训和行为的变化,以促进该过程。 ? 2018年的作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号